The Netherlands Cancer Institute
Clinical trials sponsored by The Netherlands Cancer Institute, explained in plain language.
-
New combo therapy aims to cut hormone therapy for prostate cancer patients
Disease control CompletedThis early-phase study tested a new treatment approach for men with prostate cancer that has spread to nearby lymph nodes. The standard treatment uses radiation plus 2-3 years of hormone therapy, which can cause lasting side effects. Researchers added a targeted radioactive drug …
Phase: PHASE1 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
New ultrasound method could make cancer surgery more precise
Knowledge-focused CompletedThis study aimed to create a computer program that can automatically identify arteries and bones in ultrasound images taken during surgery. The goal is to help surgeons navigate more accurately when removing abdominal tumors. Fifty adult patients scheduled for abdominal surgery p…
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 04:19 UTC
-
GPS for kidney surgery: new tool aims to save healthy tissue
Knowledge-focused CompletedThis study tested a new navigation system that helps surgeons see exactly where a kidney tumor is during robot-assisted surgery. The goal was to remove only the tumor and as little healthy kidney tissue as possible. Twenty adults scheduled for this type of surgery took part. The …
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC
-
Sarcoma Patients' voices heard in new quality of life study
Knowledge-focused CompletedThis study involved 654 adults with sarcoma to understand how to better measure their health-related quality of life. Researchers interviewed patients and healthcare professionals to identify the most important issues. The goal is to create a questionnaire that captures the uniqu…
Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
New scan may predict immunotherapy success in lung cancer
Knowledge-focused CompletedThis study tested a new type of PET scan that looks for a protein called PD-L1 in tumors. The goal was to see if this scan could predict which patients with advanced lung cancer would benefit from the immunotherapy drug nivolumab. Eighty patients received the scan before starting…
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC